ABSTRACT
BACKGROUND AND PURPOSE: Caffeine is associated with a lower risk of some neurological diseases, but few prospective studies have investigated caffeine intake and risk of amyotrophic lateral sclerosis (ALS) mortality. We therefore determined associations between coffee, tea and caffeine intake, and risk of ALS mortality. METHODS: We conducted pooled analyses of eight international, prospective cohort studies, including 351 565 individuals (120 688 men and 230 877 women). We assessed coffee, tea and caffeine intake using validated food-frequency questionnaires administered at baseline. We used Cox regression to estimate study- and sex-specific risk ratios and 95% confidence intervals (CI) for ALS mortality, which were then pooled using a random-effects model. We conducted analyses using cohort-specific tertiles, absolute common cut-points and continuous measures of all exposures. RESULTS: During follow-up, 545 ALS deaths were documented. We did not observe statistically significant associations between coffee, tea or caffeine intake and risk of ALS mortality. The pooled multivariable risk ratio (MVRR) for ≥3 cups per day vs. >0 to <1 cup per day was 1.04 (95% CI, 0.74-1.47) for coffee and 1.17 (95% CI, 0.77-1.79) for tea. The pooled MVRR comparing the highest with the lowest tertile of caffeine intake (mg/day) was 0.99 (95% CI, 0.80-1.23). No statistically significant results were observed when exposures were modeled as tertiles or continuously. CONCLUSIONS: Our results do not support associations between coffee, tea or total caffeine intake and risk of ALS mortality.
Subject(s)
Amyotrophic Lateral Sclerosis/mortality , Caffeine , Coffee , Risk Assessment , Tea , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prospective StudiesABSTRACT
BACKGROUND AND AIMS: Coffee contains many biologically active compounds with potential adverse or beneficial effects on the cardiovascular system. Whether coffee consumption is associated with the risk of aortic valve stenosis (AVS) is unknown. The purpose of this study was therefore to examine the association between coffee consumption and AVS incidence. METHODS AND RESULTS: This prospective study included 71 178 men and women who provided information on their coffee consumption through a questionnaire at baseline. Incident cases of AVS were identified through linkage with the Swedish National Patient and Cause of Death Registers. During a mean follow-up of 15.2 years, 1295 participants (777 men and 518 women) were diagnosed with AVS. Coffee consumption was positively associated with risk of AVS in a dose-response manner after adjustment for age, sex, smoking, and other risk factors (P-trend = 0.005). The multivariable hazard ratios were was 1.11 (95% confidence interval 1.04-1.19) per 2 cups/day increase of coffee consumption and 1.65 (95% confidence interval 1.10-2.48) when comparing the highest (≥6 cups/day) with the lowest (<0.5 cup/day) category of coffee consumption. The association was not modified by other risk factors. CONCLUSIONS: This study provides novel evidence that high coffee consumption is associated with an increased risk of AVS.
Subject(s)
Aortic Valve Stenosis/epidemiology , Coffee/adverse effects , Aged , Aged, 80 and over , Aortic Valve Stenosis/diagnostic imaging , Female , Humans , Incidence , Male , Middle Aged , Prospective Studies , Registries , Risk Assessment , Risk Factors , Sweden/epidemiologyABSTRACT
OBJECTIVE: The potentially beneficial effects of fish consumption on stroke may be modified by major food contaminants in fish. Polychlorinated biphenyls (PCBs) in particular are proposed to play a role in the aetiology of stroke. The aim of this study was to assess the association between dietary PCB exposure and stroke risk with the intake of long-chain omega-3 fish fatty acids and fish consumption. DESIGN: The prospective population-based Swedish Mammography Cohort was examined. It was comprised of 34,591 women free of cardiovascular diseases and cancer at baseline in 1997 and followed up for 12 years. Validated estimates of dietary PCB exposure were obtained via a food frequency questionnaire at baseline. Incident cases of stroke were ascertained through register linkage. RESULTS: During 12 years of follow-up (397,309 person-years), there were 2015 incident cases of total stroke (1532 ischaemic strokes, 216 intracerebral haemorrhages, 94 subarachnoid haemorrhages and 173 unspecified strokes). Multivariable-adjusted relative risks (RR), controlled for known stroke risk factors and fish consumption, were 1.67 [95% confidence interval (CI), 1.29-2.17] for total stroke, 1.61 (95% CI, 1.19-2.17) for ischaemic stroke and 2.80 (95% CI, 1.42-5.55) for haemorrhagic stroke for women in the highest quartile of dietary PCB exposure (median 288 ng day(-1) ) compared with women in the lowest quartile (median 101 ng day(-1) ). CONCLUSION: Dietary exposure to PCBs was associated with an increased stroke risk in women, especially haemorrhagic stroke. The results provide important information regarding the risk-benefit analysis of fish consumption, particularly for cerebrovascular disease prevention.
Subject(s)
Diet/adverse effects , Fatty Acids, Omega-3/toxicity , Food Contamination , Polychlorinated Biphenyls/toxicity , Seafood/adverse effects , Stroke/chemically induced , Female , Humans , Middle Aged , Prospective Studies , Risk FactorsABSTRACT
BACKGROUND AND AIMS: We have previously shown that nutritional guidelines decreased the incidence of pressure ulcers in hip fracture patients. In the present study, we evaluate whether the nutritional biochemical markers S-IGF-1 (Insulin-like Growth Factor 1), S-Transthyretin and S-Albumin are affected by patients' energy intake, and whether the markers are useful as predictors of postoperative complications. MATERIAL AND METHODS: Quasi-experimental design, with one intervention and one control group, as well as pre- and post-study measurements. Eighty-eight hip fracture patients were included: 42 in the control group and 46 in the intervention group. The control group received regular nutritional support pre- and postoperatively, while the intervention group received nutritional support that followed new, improved clinical guidelines from admission to five days postoperatively. S-Albumin, S-Transthyretin, C-Reactive Protein (S-CRP) and S-IGF-1 were analysed at admission and five days postoperatively as well as complications like pressure ulcer and infection. RESULTS: The intervention group had a significantly higher energy intake; for example, 1636 kcal versus 852 kcal postoperative day 1. S-IGF-1 levels decreased significantly in the control group, while no decrease in the intervention group. S-Albumin and S-Transthyretin decreased and S-CRP increased significantly in both groups, indicating that those markers were not affected short-term by a high-energy intake. There was no correlation between short-term post-operative complications and S-IGF-1, S-Transthyretin or S-Albumin at admission. CONCLUSION: The results of our study showed that S-IGF-1 can be used as a short-term nutritional biochemical marker, as it was affected by a five-day high-energy regimen. However, neither S-IGF-1, S-Transthyretin or S-Albumin were useful in predicting postoperative complications within five days postoperatively.
Subject(s)
Energy Intake/physiology , Hip Fractures/surgery , Insulin-Like Growth Factor I/metabolism , Nutritional Support/methods , Perioperative Care/methods , Serum Albumin/metabolism , Aged , Aged, 80 and over , Arthroplasty, Replacement, Hip , Biomarkers/blood , C-Reactive Protein/metabolism , Dietary Supplements , Female , Fracture Fixation , Hip Fractures/blood , Humans , Male , Middle Aged , Nutritional Status/physiology , Postoperative Complications/etiology , Postoperative Complications/prevention & control , Practice Guidelines as Topic , Prealbumin/metabolismABSTRACT
Fluorescence in situ hybridization (FISH) was used for direct detection of Escherichia coli on pipe surfaces and coupons in drinking water distribution networks. Old cast iron main pipes were removed from water distribution networks in France, England, Portugal, and Latvia, and E. coli was analyzed in the biofilm. In addition, 44 flat coupons made of cast iron, polyvinyl chloride, or stainless steel were placed into and continuously exposed to water on 15 locations of 6 distribution networks in France and Latvia and examined after 1 to 6 months exposure to the drinking water. In order to increase the signal intensity, a peptide nucleic acid (PNA) 15-mer probe was used in the FISH screening for the presence or absence of E. coli on the surface of pipes and coupons, thus reducing occasional problems of autofluorescence and low fluorescence of the labeled bacteria. For comparison, cells were removed from the surfaces and examined with culture-based or enzymatic (detection of beta-d-glucuronidase) methods. An additional verification was made by using PCR. Culture method indicated presence of E. coli in one of five pipes, whereas all pipes were positive with the FISH methods. E. coli was detected in 56% of the coupons using PNA FISH, but no E. coli was detected using culture or enzymatic methods. PCR analyses confirmed the presence of E. coli in samples that were negative according to culture-based and enzymatic methods. The viability of E. coli cells in the samples was demonstrated by the cell elongation after resuscitation in low-nutrient medium supplemented with pipemidic acid, suggesting that the cells were present in an active but nonculturable state, unable to grow on agar media. E. coli contributed to ca. 0.001 to 0.1% of the total bacterial number in the samples. The presence and number of E. coli did not correlate with any of physical and/or chemical characteristic of the drinking water (e.g., temperature, chlorine, or biodegradable organic matter concentration). We show here that E. coli is present in the biofilms of drinking water networks in Europe. Some of the cells are metabolically active but are often not detected due to limitations of traditionally used culture-based methods, indicating that biofilm should be considered as a reservoir that must be investigated further in order to evaluate the risk for human health.
Subject(s)
Biofilms , Escherichia coli/genetics , Water Microbiology , Water Supply/analysis , DNA, Bacterial/genetics , England , Environmental Monitoring/methods , Escherichia coli/isolation & purification , France , In Situ Hybridization, Fluorescence , Latvia , Polymerase Chain Reaction , Portugal , RNA, Ribosomal, 16S/genetics , Water Purification/instrumentationABSTRACT
OBJECTIVE: To assess the association between magnesium intake and risk of type 2 diabetes. DESIGN: Meta-analysis of prospective cohort studies. DATA SOURCES: We retrieved studies published in any language by systematically searching MEDLINE from 1966 to February 2007 and by manually examining the references of the original articles. STUDY SELECTION: We included prospective cohort studies reporting relative risks with 95% confidence intervals for the association between magnesium intake and incidence of type 2 diabetes. RESULTS: The seven identified cohort studies of magnesium intake [from foods only (n = 4) or from foods and supplements combined (n = 3)] and incidence of type 2 diabetes included 286,668 participants and 10,912 cases. All but one study found an inverse relation between magnesium intake and risk of type 2 diabetes, and in four studies the association was statistically significant. The overall relative risk for a 100 mg day(-1) increase in magnesium intake was 0.85 (95% CI, 0.79-0.92). Results were similar for intake of dietary magnesium (RR, 0.86; 95% CI, 0.77-0.95) and total magnesium (RR, 0.83; 95% CI, 0.77-0.89). There was no evidence of publication bias (P = 0.99). CONCLUSIONS: Magnesium intake was inversely associated with incidence of type 2 diabetes. This finding suggests that increased consumption of magnesium-rich foods such as whole grains, beans, nuts, and green leafy vegetables may reduce the risk of type 2 diabetes.
Subject(s)
Diabetes Mellitus, Type 2/etiology , Magnesium/administration & dosage , Dietary Supplements , Female , Food , Humans , Male , Prospective Studies , Risk Assessment/methods , Risk FactorsSubject(s)
Bacteria , Bronchitis/prevention & control , Cell Extracts , Expectorants/therapeutic use , Lung Diseases, Obstructive/prevention & control , Acetylcysteine/therapeutic use , Adjuvants, Immunologic/administration & dosage , Ambroxol/therapeutic use , Antioxidants/therapeutic use , Bronchitis/immunology , Chronic Disease , Haemophilus influenzae/immunology , Humans , Interferon Inducers/administration & dosage , Lung Diseases, Obstructive/immunologyABSTRACT
Seventeen patients with probable Alzheimer's disease (AD), 7 patients with frontal lobe dementia (FLD) and 19 control subjects (NOR) were examined by (99m)Tc-d,l- hexamethylpropylene amine oxime ((99m)Tc-HMPAO) SPECT. Images were standardised in the same 3D space and averaged within each group. After normalisation, the three sets of images were analysed in all cerebral lobes, hippocampus, thalamus and basal ganglia. In AD, the (99m)Tc-HMPAO uptake values were significantly reduced, as compared to NOR, in the parietal, temporal and insular lobes. In patients with FLD, the uptake was altered in all lobes with the exception of the parietal lobe. The uptake in the nucleus caudatus decreased significantly in both AD and FLD as compared to NOR. The uptake in the anterior cingulate cortex was significantly reduced in FLD. Subtraction images highlighted all significantly decreased areas. In conclusion, standardising SPECT in a common space and subtracting data from a control group improves the visual interpretation of images. In this study, the typical temporo-parietal and fronto-parietal (99m)Tc-HMPAO uptake reductions were found in AD and FLD, respectively. The uptake in the nucleus caudatus was found to decrease significantly in AD and FLD and the one in the anterior cingulate cortex was reduced in FLD.
Subject(s)
Alzheimer Disease/diagnosis , Frontal Lobe/metabolism , Tomography, Emission-Computed, Single-Photon , Aged , Basal Ganglia/metabolism , Brain Mapping/instrumentation , Cerebral Cortex/metabolism , Female , Hippocampus/metabolism , Humans , Male , Oximes/pharmacokinetics , Parietal Lobe/metabolism , Radiopharmaceuticals/pharmacokinetics , Retrospective Studies , Temporal Lobe/metabolism , Thalamus/metabolismABSTRACT
In previous studies we have described structural and functional changes in rat bone tissue caused by 3,3',4,4',5-pentachlorobiphenyl (PCB126). Some of the effects caused by PCB126 resemble those found in vitamin C-deficient rats, as well as those found in rats with a high dietary intake of vitamin A. The present investigation was designed to determine if these PCB126-induced changes could be inhibited by addition of vitamin C to the drinking water and if they could be evoked by vitamin A administration. Five groups of female rats were used in this study, which lasted for 12 weeks. Three of the groups were exposed to PCB126 (total dose 320 microgram/kg, bw), either alone or in combination with vitamin C added to the drinking water (1 and 10 g/l, respectively). One group was given feed with increased level of vitamin A (600000 U/kg pellet) and the fifth group served as controls. Using peripheral quantitative computed tomography (pQCT), it was found that PCB126 increased trabecular density and cortical thickness, but reduced the trabecular area. Furthermore, maximum torque and stiffness of the humerus during torsional testing and serum osteocalcin levels were reduced by PCB126. Of the PCB126 induced effects observed, addition of vitamin C only inhibited the reduction of serum osteocalcin. Like PCB126 vitamin A supplementation increased the inorganic content and the bone density and also reduced the trabecular area and polar moment of inertia but did not increase the cortical thickness or reduce maximum torque, stiffness or serum osteocalcin level. Apparently, the effects induced by PCB126 are not mediated either via decreased vitamin C level or increased vitamin A level.
Subject(s)
Ascorbic Acid/pharmacology , Bone and Bones/drug effects , Estrogen Antagonists/toxicity , Polychlorinated Biphenyls/toxicity , Vitamin A/pharmacology , Animals , Body Weight/drug effects , Bone and Bones/anatomy & histology , Bone and Bones/metabolism , Diaphyses/anatomy & histology , Diaphyses/drug effects , Diaphyses/metabolism , Diet , Epiphyses/anatomy & histology , Epiphyses/drug effects , Epiphyses/metabolism , Female , Humerus/anatomy & histology , Humerus/drug effects , Humerus/metabolism , Organ Size/drug effects , Osteocalcin/pharmacology , Rats , Rats, Sprague-Dawley , Tomography, X-Ray ComputedABSTRACT
BACKGROUND: Spinal cord stimulation (SCS) has been shown to have antianginal and anti-ischemic effects in severe angina pectoris. The present study was performed to investigate whether SCS can be used as an alternative to coronary artery bypass grafting (CABG) in selected patient groups, ie, patients with no proven prognostic benefit from CABG and with an increased surgical risk. METHODS AND RESULTS: One hundred four patients were randomized (SCS, 53; CABG, 51). The patients were assessed with respect to symptoms, exercise capacity, ischemic ECG changes during exercise, rate-pressure product, mortality, and cardiovascular morbidity before and 6 months after the operation. Both groups had adequate symptom relief (P<.0001), and there was no difference between SCS and CABG. The CABG group had an increase in exercise capacity (P=.02), less ST-segment depression on maximum (P=.005) and comparable (P=.0009) workloads, and an increase in the rate-pressure product both at maximum (P=.0003) and comparable (P=.03) workloads compared with the SCS group. Eight deaths occurred during the follow-up period, 7 in the CABG group and 1 in the SCS group. On an intention-to-treat basis, the mortality rate was lower in the SCS group (P=.02). Cerebrovascular morbidity was also lower in the SCS group (P=.03). CONCLUSIONS: CABG and SCS appear to be equivalent methods in terms of symptom relief in this group of patients. Effects on ischemia, morbidity, and mortality should be considered in the choice of treatment method. Taking all factors into account, it seems reasonable to conclude that SCS may be a therapeutic alternative for patients with an increased risk of surgical complications.
Subject(s)
Angina Pectoris/surgery , Angina Pectoris/therapy , Coronary Artery Bypass , Electric Stimulation Therapy , Adult , Aged , Aged, 80 and over , Angina Pectoris/mortality , Cerebrovascular Circulation , Coronary Circulation , Cross-Over Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Morbidity , Myocardial Ischemia/mortality , Myocardial Ischemia/surgery , Myocardial Ischemia/therapy , Postoperative Complications/epidemiology , Prospective Studies , Risk Factors , Spinal CordABSTRACT
The effect of oral zinc supplementation in patients with cystic fibrosis (CF) was investigated in a placebo-controlled, double-blind, crossover study with each treatment period covering 6 months. CF patients (n = 13, aged 2 years, 3 months to 19 years, 1 month) started with placebo and after 6 months, they received zinc therapy. Another 13 patients (aged 3 years, 5 months to 16 years, 10 months) started in the reverse order. Before zinc supplementation, all CF patients had low plasma levels of zinc which normalized during treatment. This effect was, however, transient. CF patients also had low concentrations of plasma selenium. A small decrease in the number of leukocytes was also noted during zinc therapy. In response to zinc treatment, no changes in the clinical status of the patients were observed either by the investigators or by the patients. Growth velocity was the same during the placebo and zinc treatment periods. No significant changes in lung function occurred in response to either placebo or zinc. It appears that the observed low plasma zinc concentration in CF patients was due to an impaired zinc absorption from the gut which was counteracted by an increased supply of oral zinc. No beneficial effect from zinc supplementation on clinical status, growth velocity, or lung function was found in this study.
Subject(s)
Cystic Fibrosis/drug therapy , Zinc/therapeutic use , Adolescent , Adult , Child , Child, Preschool , Cystic Fibrosis/blood , Cystic Fibrosis/metabolism , Double-Blind Method , Female , Humans , Intestinal Absorption , Male , Trace Elements/blood , Zinc/bloodABSTRACT
In 14 adult rabbits the middle third of the ulna was resected bilaterally followed by reimplantation of resected bone after autoclaving on one side and transplantation of allogeneic bone on the other. In 7 animals the bilateral implants were supplemented with allogeneic bone matrix. The reconstructions were studied in vivo by serial radiography, scintigraphy, and bone mineral determination. The animals were killed at 16 weeks, and the ulnar reconstructions further studied by high resolution radiography, 45Ca autoradiography, and histology. In both types of nonsupplemented reconstructions, new bone formation was poor; nonunion occurred in three out of seven autoclaved reimplants and in five out of seven allogeneic transplants. Supplemented with allogeneic bone matrix, both types of reconstructions exhibited abundant new bone formation and complete incorporation of all implants. Enhancement of new bone formation is probably more important than the type of nonviable bone graft chosen for reconstruction of large skeletal defects.
Subject(s)
Bone Transplantation , Replantation , Sterilization , Tissue Preservation , Animals , Bone Matrix/transplantation , Bone and Bones/anatomy & histology , Bone and Bones/metabolism , Bone and Bones/surgery , Freezing , Male , Osteogenesis , Rabbits , Tissue Survival , Transplantation, HomologousABSTRACT
Ultrastructural evidence was obtained from vitamin D deficient and calcium deficient rats that the sarcoplasmic reticulum (SR) is involved in the intracellular calcium transport of the muscle cell. In the absence of vitamin D there was a relative decrease in SR volume and a compensatory increase in mitochondrial volume. Administration of exogenous doses of 1,25-dihydroxycholecalciferol significantly increased SR volume, while mitochondrial volume correspondingly decreased. This supports the hypothesis that the production of calcium binding proteins within the SR is influenced by active metabolites of vitamin D.
Subject(s)
Calcium/deficiency , Dihydroxycholecalciferols/pharmacology , Hydroxycholecalciferols/pharmacology , Muscles/drug effects , Vitamin D Deficiency/pathology , Animals , Calcium/blood , Male , Mitochondria, Muscle/ultrastructure , Muscles/ultrastructure , Phosphorus/blood , Protein Binding/drug effects , Rats , Sarcoplasmic Reticulum/ultrastructureABSTRACT
The effects of selective parathyroidectomy on the adaptation to a low calcium intake were studied in one-year-old male rats. Parathyroidectomized animals showed increased net absorption of intestinal calcium compared to that of intact animals both at a normal and at a low intake of dietary calcium. The difference was highly significant on the low level of dietary calcium. In the parathyroidectomized animals, significantly higher values were found in the group of rats fed the low calcium diet than in those supplied the calcium supplemented diet. Urinary calcium excretion was reduced because of the reduced plasma calcium level. While there was no disturbance of intestinal calcium absorption, selective parathyroidectomy resulted in a reduced ability to mobilize skeletal calcium as shown in a previous study. This was found to be necessary for the adaptation to a low calcium intake in the adult animal.